Cibus (NASDAQ:CBUS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Cibus (NASDAQ:CBUS) from a sell rating to a hold rating in a research note published on Saturday.

Separately, Weiss Ratings cut shares of Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, June 29th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $9.00.

Cibus Stock Up 6.5%

Shares of NASDAQ:CBUS opened at $1.81 on Friday. The company has a market capitalization of $138.16 million, a price-to-earnings ratio of -0.92 and a beta of 1.65. Cibus has a 52 week low of $1.09 and a 52 week high of $4.19. The firm has a 50 day moving average of $1.51 and a 200 day moving average of $1.97.

Cibus (NASDAQ:CBUS) last posted its earnings results on Thursday, May 14th. The company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The company had revenue of $1.68 million for the quarter, compared to analysts’ expectations of $1.61 million. Cibus had a negative return on equity of 200.87% and a negative net margin of 2,366.33%. On average, sell-side analysts expect that Cibus will post -1.05 EPS for the current year.

Institutional Trading of Cibus

A number of institutional investors have recently made changes to their positions in CBUS. Rockland Trust Co. acquired a new position in Cibus during the 2nd quarter valued at about $41,000. Bank of America Corp DE raised its stake in Cibus by 324.2% in the first quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock valued at $147,000 after buying an additional 56,830 shares during the last quarter. Weiss Asset Management LP acquired a new stake in Cibus in the first quarter worth about $1,758,000. OMERS ADMINISTRATION Corp acquired a new stake in Cibus in the first quarter worth about $66,000. Finally, Renaissance Technologies LLC grew its stake in shares of Cibus by 42.5% during the first quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock worth $196,000 after acquiring an additional 29,500 shares during the last quarter. Institutional investors and hedge funds own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.